We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Strand and ChemAxon Enter into Collaboration
News

Strand and ChemAxon Enter into Collaboration

Strand and ChemAxon Enter into Collaboration
News

Strand and ChemAxon Enter into Collaboration

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Strand and ChemAxon Enter into Collaboration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Strand Life Sciences has announced that it has integrated ChemAxon’s JChem suite of software with admetis, its tool for modeling and predicting drug-relevant properties of molecules in silico. The integrated offering will be launched in the early part of Q1 2006.

admetis is a tool for modeling and predicting drug-relevant properties of molecules in silico.

It is designed to give users the power to build custom models using their own data. This is made possible through model-building workflows based on Strand's expertise in in silico model building.

admetis comes packaged with its pre-built models, truPK and truTox, for predicting Bioavailability, Protein binding, Volume distribution, Elimination half life, Rate of absorption and hERG binding.

admetis has an extensive data mining and visualization module that supports an embedded chemical structure viewer.

The inclusion of ChemAxon’s JChem toolkit provides admetis with a chemically aware data management and search framework.

admetis users will be able to enjoy chemical editing and visualization capabilities as well as the power to build complex queries using structural and non-structural data.

"admetis couples pre-built models with a workflow-based modeling platform making it a distinct offering," said Kas Subramanian, CSO, Strand Life Sciences.

"Some of the key features of JChem directly address the requests from our prospects and customers. We believe that this integration will benefit our customers," he added.

"We are happy that we have such a good fit with the admetis offering and given Strands expertise and ambitious plans for future development we see a bright future for the collaboration," said Ferenc Csizmadia, CEO of ChemAxon.

Advertisement